IonQ Q2 revenue jumps 287%, hitting record high on quantum computer deployments

The current average analyst rating on the shares is buy, with 11 strong buy or buy ratings, 3 hold ratings and no sell or strong sell ratings.

Wall Street's median 12-month price target for IonQ, Inc. is $69.86, about 67.4% above its Aug. 4 closing price of $41.72.

The company said its second-quarter net loss widened to $1.87 billion, or $5.08 per share, compared with analysts' expectation for a $107.54 million loss.

IonQ said international, commercial, and multi-product segments contributed 50%, 60%, and 25% of Q2 revenue, respectively. It also cited new agreements with Anduril and Sandia National Laboratories, along with expanded quantum security and communications offerings.